🇺🇸 FDA
Pipeline program

18F-Canagliflozin, Invokana 300 mg film-coated tablets

20725

Approved small_molecule active

Quick answer

18F-Canagliflozin, Invokana 300 mg film-coated tablets for Chronic Kidney disease is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Chronic Kidney disease
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials